In this study, we found that AST could reduce the expression of Ki67 and thus inhibit the proliferation of cancer cells, and in vivo experiments further verified that AST could inhibit the production of inflammatory factors and reduce the incidence of CAC by inhibiting the expression of proteins related to the MAPK and NF-κB pathways. Here, NFKB1 is linked to cancer.